Compare AMWL & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMWL | NSPR |
|---|---|---|
| Founded | 2006 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.8M | 77.5M |
| IPO Year | 2020 | 2009 |
| Metric | AMWL | NSPR |
|---|---|---|
| Price | $5.55 | $1.73 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $7.42 | $4.00 |
| AVG Volume (30 Days) | ★ 56.2K | 41.9K |
| Earning Date | 04-30-2026 | 03-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.06 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $2,310,000.00 |
| Revenue This Year | N/A | $22.91 |
| Revenue Next Year | $4.24 | $72.30 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.71 | $1.51 |
| 52 Week High | $9.15 | $2.93 |
| Indicator | AMWL | NSPR |
|---|---|---|
| Relative Strength Index (RSI) | 51.45 | 52.23 |
| Support Level | $4.48 | $1.70 |
| Resistance Level | $5.81 | $2.17 |
| Average True Range (ATR) | 0.34 | 0.09 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 26.90 | 39.69 |
American Well Corp is an enterprise platform and software company digitally enabling hybrid care by offering payers and health systems a technology-enabled care platform. The Amwell Platform, its cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings by enabling critical services like virtual primary care, urgent care, clinical partner programs, scheduling visits, etc. Additionally, the healthcare providers can use the platform to access familiar workflows for taking notes, prescribing, referencing clinical treatment guidelines, and other related activities. The firm also offers various paid services, including licensed clinical staffing, implementation support, workflow design, etc, to help clients execute their hybrid care strategies.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.